<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02396017</url>
  </required_header>
  <id_info>
    <org_study_id>SPLIT-PEG-CE</org_study_id>
    <nct_id>NCT02396017</nct_id>
  </id_info>
  <brief_title>Split-dose Versus Single-dose Polyethylene Glycol Regimen for Capsule Endoscopy</brief_title>
  <official_title>Split-dose Versus Single-dose Polyethylene Glycol Regimen for Capsule Endoscopy Is Timing of Preparation for Capsule Endoscopy the Key for the Best Small-bowel Cleansing?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Hospitalar Lisboa Ocidental</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro Hospitalar Lisboa Ocidental</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the small bowel cleanliness for wireless capsule endoscopy using two different
      Polyethylene Glycol administration schedules (before the wireless capsule endoscopy ingestion
      versus in a split-dose fashion).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The image quality obtained from the wireless capsule endoscopy improves its diagnostic yield.
      The amount of visualized mucosa is in direct correlation with the diagnostic yield.
      Nonetheless, frequently, the quality of the image obtained is hampered by the presence of
      bubbles, debris, bile and enteric fluid. Therefore many efforts have been putted in order to
      eliminate this factor such as the use of prokinetics, simethicone and bowel purgatives. The
      latter (namely the polyethylene glycol - PEG - solution) has accumulated evidence and is,
      therefore, recommended by the last European guidelines. Usually, the cleansing starts and
      finish in the day before the capsule endoscopy ingestion.

      We hypothesized that, similarly to what had become evidence to large bowel cleansing, a
      shorter gap between the polyethylene glycol intake and the exam could provide a better
      capsule endoscopy image quality and therefore gauging our diagnostic yield.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Small-bowel cleanliness</measure>
    <time_frame>at the end of capsule endoscopy exploration</time_frame>
    <description>The cleansing quality of the small-bowel will be evaluated according to the system validated by Brotz et al., using the quantitative index (QI), because this score is less susceptible to the subjective element. The used cut-off value accepted for an adequate small-bowel cleansing was ≥ 8 points.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The number of all the observed lesions</measure>
    <time_frame>at the end of capsule endoscopy exploration</time_frame>
    <description>Estimate the number of all the observed lesions on the recording according to their hemorrhagic potential.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The clinical tolerance questionnaire</measure>
    <time_frame>at the end of capsule endoscopy exploration</time_frame>
    <description>Evaluate the clinical tolerance and the acceptability of the bowel preparation with the oral polyethylene glycol solution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The transit time</measure>
    <time_frame>at the end of capsule endoscopy exploration</time_frame>
    <description>Compare gastric transit time and the small bowel transit time.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Bowel Preparation</condition>
  <arm_group>
    <arm_group_label>Single-dose Polyethylene Glycol regimen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug: Polyethylene Glycol Intervention: 2 liters of Polyethylene Glycol will be given in the day before Capsule Endoscopy ingestion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Split-dose Polyethylene Glycol regimen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug: Polyethylene Glycol Intervention: 1 liter of Polyethylene Glycol will be given in the day before Capsule Endoscopy ingestion and another 1 liter Polyethylene Glycol will be given in the same day of Capsule Endoscopy ingestion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Capsule endoscopy</intervention_name>
    <description>Endoscopic device</description>
    <arm_group_label>Single-dose Polyethylene Glycol regimen</arm_group_label>
    <arm_group_label>Split-dose Polyethylene Glycol regimen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Polyethylene Glycol</intervention_name>
    <description>Bowel purgative</description>
    <arm_group_label>Single-dose Polyethylene Glycol regimen</arm_group_label>
    <arm_group_label>Split-dose Polyethylene Glycol regimen</arm_group_label>
    <other_name>PEG</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult patients referred to our institution for CE during the study period

        Exclusion Criteria:

          -  inpatients, bedridden, patients with clinical evidence of active bleeding, past
             history of abdominal surgery, abdominal or pelvic radiation therapy, occlusion, bowel
             perforation (suspected or confirmed), use of oral iron replacement therapy, severe
             cardiopulmonary, renal or hepatic disease, pregnancy, hypersensitivity to any
             components of the preparation, patients that didn't complete the preparation protocol,
             patients with incomplete enteroscopies (a complete enteroscopy is defined by the
             visualization of the mucosa from the duodenal bulb to the cecum), patients enrolled in
             other clinical studies and patients who didn't signed informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cristina Chagas, MD</last_name>
    <role>Study Director</role>
    <affiliation>Gastroenterology Department, Hospital Egas Moniz, Centro Hospitalar Lisboa Ocidental</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pedro Magalhães-Costa, MD</last_name>
    <phone>00351-96-3532531</phone>
    <email>pmagalhaescosta@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gastroenterology Department, Hospital Egas Moniz</name>
      <address>
        <city>Lisboa</city>
        <zip>1349-019 Lisboa</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pedro Magalhães-Costa, MD</last_name>
      <phone>00351963532531</phone>
      <email>pmagalhaescosta@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <reference>
    <citation>Rokkas T, Papaxoinis K, Triantafyllou K, Pistiolas D, Ladas SD. Does purgative preparation influence the diagnostic yield of small bowel video capsule endoscopy?: A meta-analysis. Am J Gastroenterol. 2009 Jan;104(1):219-27. doi: 10.1038/ajg.2008.63.</citation>
    <PMID>19098872</PMID>
  </reference>
  <reference>
    <citation>Ladas SD, Triantafyllou K, Spada C, Riccioni ME, Rey JF, Niv Y, Delvaux M, de Franchis R, Costamagna G; ESGE Clinical Guidelines Committee. European Society of Gastrointestinal Endoscopy (ESGE): recommendations (2009) on clinical use of video capsule endoscopy to investigate small-bowel, esophageal and colonic diseases. Endoscopy. 2010 Mar;42(3):220-7. doi: 10.1055/s-0029-1243968. Epub 2010 Mar 1.</citation>
    <PMID>20195992</PMID>
  </reference>
  <reference>
    <citation>Brotz C, Nandi N, Conn M, Daskalakis C, DiMarino M, Infantolino A, Katz LC, Schroeder T, Kastenberg D. A validation study of 3 grading systems to evaluate small-bowel cleansing for wireless capsule endoscopy: a quantitative index, a qualitative evaluation, and an overall adequacy assessment. Gastrointest Endosc. 2009 Feb;69(2):262-70, 270.e1. doi: 10.1016/j.gie.2008.04.016. Epub 2008 Oct 11.</citation>
    <PMID>18851851</PMID>
  </reference>
  <reference>
    <citation>Hassan C, Bretthauer M, Kaminski MF, Polkowski M, Rembacken B, Saunders B, Benamouzig R, Holme O, Green S, Kuiper T, Marmo R, Omar M, Petruzziello L, Spada C, Zullo A, Dumonceau JM; European Society of Gastrointestinal Endoscopy. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2013;45(2):142-50. doi: 10.1055/s-0032-1326186. Epub 2013 Jan 18.</citation>
    <PMID>23335011</PMID>
  </reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2015</study_first_submitted>
  <study_first_submitted_qc>March 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2015</study_first_posted>
  <last_update_submitted>March 23, 2015</last_update_submitted>
  <last_update_submitted_qc>March 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro Hospitalar Lisboa Ocidental</investigator_affiliation>
    <investigator_full_name>Pedro Magalhães-Costa</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

